International Biotechnology Trust’s AveXis, Inc. Common Stock AVXS Stock Holding History

International Biotechnology Trust’s Portfolio AVXS Stock Details AVXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-17,000	Closed	-$2.1M	–	68
2018 Q1	$2.1M	Hold	17,000	–	–	0.82%	29
2017 Q4	$1.88M	Hold	17,000	–	–	0.66%	39
2017 Q3	$1.64M	Buy	+17,000	New	+$1.53M	0.64%	36

Other funds holding AVXS

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

International Biotechnology Trust's AVXS Position: Q2 2018 in Review

International Biotechnology Trust sold out of AveXis, Inc. Common Stock (AVXS) in Q2 2018, closing a stake of 17,000 shares — an estimated $2.1M sold.

International Biotechnology Trust first reported a position in AVXS in Q3 2017 and held it in 3 quarters. The position peaked at $2.1M in Q1 2018. 1 fund tracked by Wall St. Rank holds AVXS as of Q2 2018.

International Biotechnology Trust reported no remaining AveXis, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
International Biotechnology Trust sold 17,000 AveXis, Inc. Common Stock shares in Q2 2018, an estimated $2.1M.
International Biotechnology Trust first reported a position in AveXis, Inc. Common Stock in Q3 2017 and held it in 3 quarters.
International Biotechnology Trust's AveXis, Inc. Common Stock position peaked at $2.1M in Q1 2018.
1 fund tracked by Wall St. Rank held AveXis, Inc. Common Stock as of Q2 2018.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.